143 related articles for article (PubMed ID: 10432931)
1. Abnormalities of tumor suppressor genes P16 and P15 in primary maxillofacial squamous cell carcinomas.
Zhao Y; Zhang S; Fu B; Xiao C
Cancer Genet Cytogenet; 1999 Jul; 112(1):26-33. PubMed ID: 10432931
[TBL] [Abstract][Full Text] [Related]
2. Inactivation of the p14(ARF), p15(INK4B) and p16(INK4A) genes is a frequent event in human oral squamous cell carcinomas.
Shintani S; Nakahara Y; Mihara M; Ueyama Y; Matsumura T
Oral Oncol; 2001 Sep; 37(6):498-504. PubMed ID: 11435176
[TBL] [Abstract][Full Text] [Related]
3. Identification and sequencing of the Syrian Golden hamster (Mesocricetus auratus) p16(INK4a) and p15(INK4b) cDNAs and their homozygous gene deletion in cheek pouch and pancreatic tumor cells.
Muscarella P; Knobloch TJ; Ulrich AB; Casto BC; Moniaux N; Wittel UA; Melvin WS; Pour PM; Song H; Gold B; Batra SK; Weghorst CM
Gene; 2001 Oct; 278(1-2):235-43. PubMed ID: 11707341
[TBL] [Abstract][Full Text] [Related]
4. Molecular analysis of the INK4A and INK4B gene loci in human breast cancer cell lines and primary carcinomas.
Bisogna M; Calvano JE; Ho GH; Orlow I; Cordón-Cardó C; Borgen PI; Van Zee KJ
Cancer Genet Cytogenet; 2001 Mar; 125(2):131-8. PubMed ID: 11369056
[TBL] [Abstract][Full Text] [Related]
5. The study of p16 and p15 gene methylation in head and neck squamous cell carcinoma and their quantitative evaluation in plasma by real-time PCR.
Wong TS; Man MW; Lam AK; Wei WI; Kwong YL; Yuen AP
Eur J Cancer; 2003 Sep; 39(13):1881-7. PubMed ID: 12932666
[TBL] [Abstract][Full Text] [Related]
6. The p15(INK4b)/p16(INK4a)/RB1 pathway is frequently deregulated in human pituitary adenomas.
Ogino A; Yoshino A; Katayama Y; Watanabe T; Ota T; Komine C; Yokoyama T; Fukushima T
J Neuropathol Exp Neurol; 2005 May; 64(5):398-403. PubMed ID: 15892297
[TBL] [Abstract][Full Text] [Related]
7. Molecular analysis of P16(Ink4)/CDKN2 and P15(INK4B)/MTS2 genes in primary human testicular germ cell tumors.
Heidenreich A; Gaddipati JP; Moul JW; Srivastava S
J Urol; 1998 May; 159(5):1725-30. PubMed ID: 9554401
[TBL] [Abstract][Full Text] [Related]
8. Inactivation of tumor suppressor genes p15(INK4b) and p16(INK4a) in primary cutaneous B cell lymphoma.
Child FJ; Scarisbrick JJ; Calonje E; Orchard G; Russell-Jones R; Whittaker SJ
J Invest Dermatol; 2002 Jun; 118(6):941-8. PubMed ID: 12060387
[TBL] [Abstract][Full Text] [Related]
9. p16 is a major inactivation target in hepatocellular carcinoma.
Jin M; Piao Z; Kim NG; Park C; Shin EC; Park JH; Jung HJ; Kim CG; Kim H
Cancer; 2000 Jul; 89(1):60-8. PubMed ID: 10897001
[TBL] [Abstract][Full Text] [Related]
10. Deletion and methylation of the tumour suppressor gene p16/CDKN2 in primary head and neck squamous cell carcinoma.
González MV; Pello MF; López-Larrea C; Suárez C; Menéndez MJ; Coto E
J Clin Pathol; 1997 Jun; 50(6):509-12. PubMed ID: 9378820
[TBL] [Abstract][Full Text] [Related]
11. [Homozygous deletion of p16 and p15 genes in laryngeal squamous cell carcinoma].
Li F; Kang N; Li Y; He G; Lin C; Sun X; Gao H; Sun K
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2002 Feb; 19(1):30-2. PubMed ID: 11836682
[TBL] [Abstract][Full Text] [Related]
12. Aberrant methylation of p14(ARF), p15(INK4b) and p16(INK4a) genes and location of the primary site in pulmonary squamous cell carcinoma.
Furonaka O; Takeshima Y; Awaya H; Ishida H; Kohno N; Inai K
Pathol Int; 2004 Aug; 54(8):549-55. PubMed ID: 15260845
[TBL] [Abstract][Full Text] [Related]
13. Infrequent mutations and no methylation of CDKN2A (P16/MTS1) and CDKN2B (p15/MTS2) in hepatocellular carcinoma in Taiwan.
Lin YW; Chen CH; Huang GT; Lee PH; Wang JT; Chen DS; Lu FJ; Sheu JC
Eur J Cancer; 1998 Oct; 34(11):1789-95. PubMed ID: 9893670
[TBL] [Abstract][Full Text] [Related]
14. Deletion of the p16 and p15 genes in human bladder tumors.
Orlow I; Lacombe L; Hannon GJ; Serrano M; Pellicer I; Dalbagni G; Reuter VE; Zhang ZF; Beach D; Cordon-Cardo C
J Natl Cancer Inst; 1995 Oct; 87(20):1524-9. PubMed ID: 7563186
[TBL] [Abstract][Full Text] [Related]
15. Association of low p16INK4a and p15INK4b mRNAs expression with their CpG islands methylation with human hepatocellular carcinogenesis.
Qin Y; Liu JY; Li B; Sun ZL; Sun ZF
World J Gastroenterol; 2004 May; 10(9):1276-80. PubMed ID: 15112341
[TBL] [Abstract][Full Text] [Related]
16. Influence of methylated p15 and p16 genes on clinicopathological features in colorectal cancer.
Ishiguro A; Takahata T; Saito M; Yoshiya G; Tamura Y; Sasaki M; Munakata A
J Gastroenterol Hepatol; 2006 Aug; 21(8):1334-9. PubMed ID: 16872319
[TBL] [Abstract][Full Text] [Related]
17. Alteration of p16 and p15 genes in human uterine tumours.
Nakashima R; Fujita M; Enomoto T; Haba T; Yoshino K; Wada H; Kurachi H; Sasaki M; Wakasa K; Inoue M; Buzard G; Murata Y
Br J Cancer; 1999 May; 80(3-4):458-67. PubMed ID: 10408854
[TBL] [Abstract][Full Text] [Related]
18. Expression of p15 and p15.5 products in neuroendocrine lung tumours: relationship with p15(INK4b) methylation status.
Chaussade L; Eymin B; Brambilla E; Gazzeri S
Oncogene; 2001 Oct; 20(45):6587-96. PubMed ID: 11641784
[TBL] [Abstract][Full Text] [Related]
19. Deregulation of the TP53/p14ARF tumor suppressor pathway in low-grade diffuse astrocytomas and its influence on clinical course.
Watanabe T; Katayama Y; Yoshino A; Komine C; Yokoyama T
Clin Cancer Res; 2003 Oct; 9(13):4884-90. PubMed ID: 14581362
[TBL] [Abstract][Full Text] [Related]
20. Molecular analysis of a family of cyclin-dependent kinase inhibitor genes (p15/MTS2/INK4b and p18/INK4c) in non-small cell lung cancers.
Kawamata N; Miller CW; Koeffler HP
Mol Carcinog; 1995 Dec; 14(4):263-8. PubMed ID: 8519415
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]